Saeed Motahari
2017
In 2017, Saeed Motahari earned a total compensation of $3.7M as President, CEO and Director at INSYS Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $648,000 |
|---|---|
| Option Awards | $2,178,541 |
| Salary | $454,327 |
| Stock Awards | $348,810 |
| Other | $65,321 |
| Total | $3,694,999 |
Motahari received $2.2M in option awards, accounting for 59% of the total pay in 2017.
Motahari also received $648K in non-equity incentive plan, $454.3K in salary, $348.8K in stock awards and $65.3K in other compensation.
Rankings
In 2017, Saeed Motahari's compensation ranked 2,833rd out of 14,666 executives tracked by ExecPay. In other words, Motahari earned more than 80.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,833 out of 14,666 | 81st |
Division Manufacturing | 969 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 258 out of 2,075 | 88th |
Industry group Drugs | 197 out of 1,731 | 89th |
Industry Pharmaceutical Preparations | 156 out of 1,333 | 88th |
Source: SEC filing on April 16, 2018.
Motahari's colleagues
We found five more compensation records of executives who worked with Saeed Motahari at INSYS Therapeutics in 2017.
2017
Franc Del Fosse
INSYS Therapeutics
General Counsel
2017
Andrew Long
INSYS Therapeutics
Chief Financial Officer
2017
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
2017
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
2017
John Kapoor
INSYS Therapeutics